Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) fell 20.1% on Tuesday . The company traded as low as $1.60 and last traded at $1.79. 824 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 9,053 shares. The stock had previously closed at $2.24.
Peak Pharmaceuticals Stock Performance
The business’s 50 day simple moving average is $1.94 and its 200 day simple moving average is $1.38.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Featured Stories
- Five stocks we like better than Peak Pharmaceuticals
- Wall Street Alert: Buy AES
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
